01 March 2017
News and Views
Links and Services
This week's publication of the New England Journal of Medicine evaluates the use of lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Somatostatin analogues are commonly used to treat symptoms associated with hormone hypersecretion
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors